1 Department of Oncology, Zhejiang People's Provincial Hospital, Hangzhou 310014, China ; 2 Department of Hepatobiliary and Pancreatic Surgery, Zhejiang People's Provincial Hospital, Hangzhou 310014, China.
Chin J Cancer Res. 2014 Apr;26(2):200-7. doi: 10.3978/j.issn.1000-9604.2014.04.07.
The objective of this study was to investigate the anti-tumor effects and analyze the mechanism of artesunate (ART) action on breast cancer in vivo using tumor transplanted nude mice.
The human breast tumor cell line MCF-7 was transplanted into nude mice, and the animals were treated with various doses of ART alone or in combination with cyclophosphamide (CTX) or normal saline (NS). The tumor inhibitory effects were observed and compared, and the ultrastructural morphology of the transplanted tumor cells was observed by electron microscopy. The apoptosis rates and cell cycle status were detected by flow cytometry (FCM). The expression of apoptosis-related proteins p53, Bcl-2, Bax and Caspase-3 were detected by immunohistochemistry and IGF-IR was detected by western blot. The expression correlation for these proteins was also analyzed.
The tumor inhibition rates in the low dose ART group, high dose ART group, CTX group and combined drug therapy group were (24.39±10.20)%, (40.24±7.02)%, (57.01±5.84)% and (68.29±5.1)%, respectively. The cell cycle was arrested in phase G0/G1 after treatment with ART. The expression of Bcl-2 was significantly reduced, and the expression levels of Bax and Caspase-3 were significantly increased in the ART group compared to the negative control saline group. There was no significant difference detected in p53 expression. The Bcl-2 level was negatively related to Bax and Caspase-3. The western blotting results showed IGF-IR downregulation.
ART inhibits the growth of MCF-7 breast tumor cell xenografts in nude mice. The anti-tumor mechanism of ART for human breast carcinoma in nude mice might be correlated with the alteration of apoptosis related protein expression, which may further induce apoptosis and inhibit cell proliferation.
本研究旨在通过荷瘤裸鼠模型,观察青蒿琥酯(ART)体内抗乳腺癌作用并探讨其作用机制。
将人乳腺癌 MCF-7 细胞株接种于裸鼠,分别给予不同剂量 ART 单药及联合环磷酰胺(CTX)或生理盐水(NS)处理,观察肿瘤抑制作用,并通过电镜观察移植瘤细胞的超微结构形态,流式细胞术(FCM)检测细胞凋亡率及细胞周期,免疫组化法检测凋亡相关蛋白 p53、Bcl-2、Bax 和 Caspase-3 的表达,Western blot 检测胰岛素样生长因子-1 受体(IGF-IR)的表达,分析各蛋白之间的表达相关性。
低、高剂量 ART 组,CTX 组及联合药物组的抑瘤率分别为(24.39±10.20)%、(40.24±7.02)%、(57.01±5.84)%和(68.29±5.1)%。ART 作用后细胞周期阻滞于 G0/G1 期,Bcl-2 表达明显降低,Bax 和 Caspase-3 表达明显升高,与阴性对照组 NS 相比差异有统计学意义(P<0.05),p53 表达差异无统计学意义。Bcl-2 与 Bax、Caspase-3 表达呈负相关。Western blot 结果显示 IGF-IR 下调。
ART 可抑制 MCF-7 乳腺癌移植瘤在裸鼠体内的生长,其抑瘤机制可能与凋亡相关蛋白表达改变有关,ART 可能通过诱导细胞凋亡、抑制细胞增殖而发挥抗肿瘤作用。